文献速递胃肠外科围术期管理与 ERAS

下肢血运重建术后手术部位感染预防策略的系统评价与Meta分析

Efficacy of Strategies Intended to Prevent Surgical Site Infection After Lower Limb Revascularization Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
PubMed 文献 · Ann Surg · 2023-03-30

本系统评价与Meta分析纳入26项RCT(4752例患者),评估12种预防下肢血运重建术后手术部位感染(SSI)的策略。结果显示,切皮前抗生素和切口负压伤口治疗(iNPWT)可降低早期(≤30天)SSI风险,且证据确定性高;iNPWT也可能降低远期(>30天)SSI风险。其他策略效果不确定,需进一步验证。

要点

  • 切皮前抗生素可显著降低早期SSI风险(RR=0.25,95%CI 0.11-0.57,高确定性)。
  • iNPWT可降低早期SSI风险(RR=0.54,95%CI 0.38-0.78,高确定性)及远期SSI风险(RR=0.44,95%CI 0.26-0.73,低确定性)。
  • 其他策略如术前超声静脉标测、横切口等效果不确定,需进一步研究。

核心结论

  • 切皮前抗生素和iNPWT可降低下肢血运重建术后早期SSI风险,证据确定性高。
  • iNPWT可能降低远期SSI风险,但证据确定性低。
  • 其他预防策略对SSI风险的影响尚不确定,需确认性试验验证。

研究设计与样本

  • 研究为系统评价与Meta分析,检索MEDLINE、EMBASE、CENTRAL和EBM Reviews(建库至2022年4月28日)。
  • 纳入26项随机对照试验(RCT),共4752例接受下肢血运重建术的周围动脉疾病患者。
  • 采用随机效应模型合并数据,使用GRADE评估证据确定性。

主要发现

  • 切皮前抗生素降低早期(≤30天)SSI风险(RR=0.25;95% CI 0.11-0.57;4项研究;I²=7.1%;高确定性)。
  • iNPWT降低早期SSI风险(RR=0.54;95% CI 0.38-0.78;5项研究;I²=7.2%;高确定性)。
  • iNPWT降低远期(>30天)SSI风险(RR=0.44;95% CI 0.26-0.73;2项研究;I²=0%;低确定性)。
  • 术前超声静脉标测(RR=0.58;95% CI 0.33-1.01;1项研究)、腹股沟横切口(RR=0.33;95% CI 0.097-1.15;1项研究)、抗生素涂层人工血管旁路移植(RR=0.74;95% CI 0.44-1.25;1项研究;257例患者)和术后给氧(RR=0.66;95% CI 0.42-1.03;1项研究)对SSI风险的影响不确定(低确定性)。

关键数值与推荐

  • 切皮前抗生素:RR=0.25(95% CI 0.11-0.57),基于4项研究,高确定性。
  • iNPWT:早期SSI的RR=0.54(95% CI 0.38-0.78),基于5项研究,高确定性;远期SSI的RR=0.44(95% CI 0.26-0.73),基于2项研究,低确定性。
  • 其他策略的RR值及95% CI见主要发现,证据确定性均为低。

临床怎么用

  • 推荐在下肢血运重建手术中切皮前使用抗生素预防SSI。
  • 可考虑使用iNPWT预防早期和远期SSI,尤其针对高风险患者。
  • 其他预防策略证据不足,临床决策需个体化并关注新证据。

局限性

  • 部分策略仅基于单一RCT,样本量有限,证据确定性低。
  • 研究间可能存在异质性,尽管部分分析I²较低。
  • 检索截止2022年4月,未纳入此后发表的研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study is to evaluate the efficacy of strategies intended to prevent surgical site infection (SSI) after lower limb revascularization surgery. BACKGROUND: SSIs are common, costly complications of lower limb revascularization surgery associated with significant morbidity and mortality. METHODS: We searched MEDLINE, EMBASE, CENTRAL, and Evidence-Based Medicine Reviews (inception to April 28, 2022). Two investigators independently screened abstracts and full-text articles, extracted data, and assessed the risk of bias. We included randomized controlled trials (RCTs) that evaluated strategies intended to prevent SSI after lower limb revascularization surgery for peripheral artery disease. We used random-effects models to pool data and GRADE to assess certainty. RESULTS: Among 6258 identified citations, we included 26 RCTs (n=4752 patients) that evaluated 12 strategies to prevent SSI. Preincision antibiotics [risk ratio (RR)=0.25; 95% CI, 0.11-0.57; n=4 studies; I2 statistic=7.1%; high certainty] and incisional negative-pressure wound therapy (iNPWT) (RR=0.54; 95% CI, 0.38-0.78; n=5 studies; I2 statistic=7.2%; high certainty) reduced pooled risk of early (≤30 days) SSI. iNPWT also reduced the risk of longer-term (>30 days) SSI (pooled-RR=0.44; 95% CI, 0.26-0.73; n=2 studies; I2 =0%; low certainty). Strategies with uncertain effects on risk of SSI included preincision ultrasound vein mapping (RR=0.58; 95% CI, 0.33-1.01; n=1 study); transverse groin incisions (RR=0.33; 95% CI, 0.097-1.15; n=1 study), antibiotic-bonded prosthetic bypass grafts (RR=0.74; 95% CI, 0.44-1.25; n=1 study; n=257 patients), and postoperative oxygen administration (RR=0.66; 95% CI, 0.42-1.03; n=1 study) (low certainty for all). CONCLUSIONS: Preincision antibiotics and iNPWT reduce the risk of early SSI after lower limb revascularization surgery. Confirmatory trials are required to determine whether other promising strategies also reduce SSI risk.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Kirkham AM, Candeliere J, McIsaac DI, et al. Efficacy of Strategies Intended to Prevent Surgical Site Infection After Lower Limb Revascularization Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Ann Surg. 2023. PMID: 36994744. doi:10.1097/SLA.0000000000005867

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。